Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Shrinking team NBB
FTE fell two years in a row, from 7.6 to 1.
Financials
Financial year 2025
CHEMCOM from Waterloo, company number BE0472909840, closed financial year 2025 with a result of € -75,173 after tax. For that financial year CHEMCOM recorded a gross margin of € 40,372 and equity of € -36,451. Compared with financial year 2024, the result moved from € -186,208 to € -75,173. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ -36,451
▼ € 75,173 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -75,173
▲ 60 % less loss than in 2024
Profit after tax over the fiscal year.
€ 128,524
▲ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -3.2 million.
People and assets in 2025
1
▼ 5.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 12,613
▼ 97% vs 2024
€ 12,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,180
▼ 99% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 231,984 | € 252,379 | € 804,883 | € 40,372 | ▼ 95% |
| Profit after taxes | € -739,457 | € -886,099 | € -186,208 | € -75,173 | ▲ € 111,035 |
| Equity | € 664,889 | € 241,692 | € 38,722 | € -36,451 | ▼ € 75,173 |
| Total debts | € 1,834,377 | € 2,031,172 | € 1,520,311 | € 172,819 | ▼ 89% |
| Cash | € 409,714 | € 356,691 | € 126,409 | € 128,524 | ▲ 2% |
| Land & buildings | € 510,295 | € 443,427 | - | - | |
| Retained profit | € -2,085,605 | € -2,971,704 | € -3,157,912 | € -3,233,086 | ▼ € 75,173 |
| Bank debt | € 1,233,010 | € 1,710,544 | € 1,161,845 | € 0 | ▼ 100% |
| Balance sheet total | € 2,499,266 | € 2,272,864 | € 1,559,033 | € 136,368 | ▼ 91% |
| Employees (FTE) | 8 | 7.6 | 6.3 | 1 | ▼ 5.3 |
Key figures of CHEMCOM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CHEMCOM?
What happened at CHEMCOM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- A.M.I.R. stepped down as director. NBB
- Charles DELWART stepped down as director. NBB
- Gaëtan WAUCQUEZ stepped down as director. NBB
- COVORIM stepped down as director. NBB
- Marc PARMENTIER stepped down as director. NBB
- HEXAGON ADVISORY SPRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 75,173. Source: NBB ↗
- CONTHEGAS CONSULTING stepped down as director. NBB
In short
From € 739,457 loss in 2022 to € 75,173 loss in 2025.
Paid € 1 in corporate taxes since 2022.
On average € 40,400 of value added per employee in 2025.
Management
The stake of Natix, Biotec, Belgocodex, ANATEO INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
CHEMCOMThe shares are held by Natix (41.6%), Biotec (20.3%), Belgocodex (3.6%) and ANATEO INVEST (1.7%). It owns 50% of TECNOSCENT itself.
Directors
According to the 2025 annual accounts
since 2024 · until 2030
Charles DELWART
Director
since 2024 · until 2030
Gaëtan WAUCQUEZ
Director
Also active at: Les Foyers Réunis, AGEMAR, EUROQUARTZ, BELUFLO, W. INVEST, Immo VSM C, ENZYBEL INTERNATIONAL
since 2024 · until 2030
Director · represented by Benedikt Van der Vorst
Also active at: ChemoSensoryX Biosciences SA, Allegro Investment Fund
since 2024 · until 2030
Director · represented by Jean-François POLLET
Also active at: ChemoSensoryX Biosciences SA
since 2024 · until 2025
Marc PARMENTIER
Director
Also active at: Association Recherche biomédicale et Diagnostic, Applications biomédicales de la Biologie moléculaire
since 2024 · until 2030
Director · represented by Thibaut HOFMAN
Also active at: Société d'Etudes Techniques au Hainaut, Blue Star Chemicals, Natix, OLFADOG BIOTECH, ENZYBEL INTERNATIONAL, BIOBEST GROUP
since 2024 · until 2030
Shareholders
Participations
50%
Establishments
Establishment units
Physical locations of this company
Drève Richelle 161 P
1410 Waterloo
Lennikse Baan 802
1070 Anderlecht
Active since 31 December 2001
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0472.909.840
- VAT number
- BE 0472.909.840
- Registered office
- Drève Richelle 161 P, 1410 Waterloo
- Names & denominations
- CHEMCOM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 September 2000
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Vervaardiging van parfums en toiletartikelen
Vervaardiging van parfums en cosmetische artikelen
Handelsbemiddeling in de groothandel in brandstoffen, ertsen, metalen en chemische producten
Handelsbemiddeling in brandstoffen, ertsen, metalen en chemische producten